The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Q3 2015 Review with Inovio Pharmaceuticals, Inc. - Developing Immunotherapies for Cancer and Infectious Diseases

SNNLive caught up with J. Joseph Kim, Ph.D., President and CEO of Inovio Pharmaceuticals, Inc. (NASDAQ: INO), at the Aegis Capital Corp. Growth Conference 2015 in Las Vegas, NV.

Share With

Thursday, October 29, 2015

   

© 2017 Stock News Now